OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MYCN Function in Neuroblastoma Development
Jörg Otte, Cecilia Dyberg, Adena Pepich, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 127

Showing 1-25 of 127 citing articles:

TRIM28 in cancer and cancer therapy
Kailang Li, Haifeng Wang, Bitao Jiang, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 8

Genetic Risk Profiling Reveals Altered Glycosyltransferase Expression as a Predictor for Patient Outcome in Neuroblastoma
Isabelle Ariane Bley, S. Behrens, Michael Spohn, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 527-527
Open Access | Times Cited: 1

Tumoral heterogeneity in neuroblastoma
Roshna Lawrence Gomez, Shakhzada Ibragimova, Revathy Ramachandran, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 6, pp. 188805-188805
Open Access | Times Cited: 35

Metal-Organic Frameworks Applications in Synergistic Cancer Photo-Immunotherapy
Pedro D. Fernandes, Fernão D. Magalhães, Rúben F. Pereira, et al.
Polymers (2023) Vol. 15, Iss. 6, pp. 1490-1490
Open Access | Times Cited: 18

New Approaches Towards Targeted Therapy for Childhood Neuroblastoma
Tina Dalianis, Monika Lukoseviciute, Stefan Holzhauser, et al.
Anticancer Research (2023) Vol. 43, Iss. 9, pp. 3829-3839
Open Access | Times Cited: 17

Targeted AURKA degradation: Towards new therapeutic agents for neuroblastoma
Muhammad Rishfi, Simon Krols, Fien Martens, et al.
European Journal of Medicinal Chemistry (2022) Vol. 247, pp. 115033-115033
Open Access | Times Cited: 25

Clinically relevant treatment of PDX models reveals patterns of neuroblastoma chemoresistance
Adriana Mañas, Kristina Aaltonen, Natalie Andersson, et al.
Science Advances (2022) Vol. 8, Iss. 43
Open Access | Times Cited: 23

KAP1 stabilizes MYCN mRNA and promotes neuroblastoma tumorigenicity by protecting the RNA m6A reader YTHDC1 protein degradation
Yi Yang, Yingwen Zhang, Guoyu Chen, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 4

Insights into the Clinical, Biological and Therapeutic Impact of Copy Number Alteration in Cancer
Shannon L. Carey-Smith, Rishi S. Kotecha, Laurence C. Cheung, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6815-6815
Open Access | Times Cited: 4

Exploring Pediatric Neuroblastoma: A Comprehensive Analysis of Adrenal and Nonadrenal Tumor Characteristics in the United States
Ghaith AlWawi, Mohammad Al-Refai, Mohd Zaki Al‐Wawi, et al.
Avicenna Journal of Medicine (2025)
Open Access

Identification of novel AURKA inhibitors against neuroblastoma using a virtual screening approach
Hongli Yin, Xue Dong, Tianyi Liu
Bioorganic Chemistry (2025) Vol. 160, pp. 108480-108480
Closed Access

Myc family proteins: Molecular drivers of tumorigenesis and resistance in neuroendocrine tumors
Hannah M. Hylton-McComas, Anna F. Cordes, Konstantinos V. Floros, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189332-189332
Open Access

Discovery, evaluation and mechanism study of WDR5-targeted small molecular inhibitors for neuroblastoma
Qilei Han, Xiang-lei Zhang, Pengxuan Ren, et al.
Acta Pharmacologica Sinica (2022) Vol. 44, Iss. 4, pp. 877-887
Closed Access | Times Cited: 16

RUNX3 Meets the Ubiquitin-Proteasome System in Cancer
Albano Toska, Nikita Modi, Lin‐Feng Chen
Cells (2023) Vol. 12, Iss. 5, pp. 717-717
Open Access | Times Cited: 10

ONC201 Suppresses Neuroblastoma Growth by Interrupting Mitochondrial Function and Reactivating Nuclear ATRX Expression While Decreasing MYCN
Jian‐Ching Wu, Chao‐Cheng Huang, Pei‐Wen Wang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1649-1649
Open Access | Times Cited: 9

STING agonist delivery by lipid calcium phosphate nanoparticles enhances immune activation for neuroblastoma
Bo Feng, Xiao Ting Lu, Guangqin Zhang, et al.
Acta Materia Medica (2023) Vol. 2, Iss. 2
Open Access | Times Cited: 9

Review: Targeting EZH2 in neuroblastoma
Jinhui Gao, Claire Fosbrook, Jane Whitney Gibson, et al.
Cancer Treatment Reviews (2023) Vol. 119, pp. 102600-102600
Open Access | Times Cited: 9

The polyamine transporter ATP13A3 mediates DFMO-induced polyamine uptake in neuroblastoma
Mujahid Azfar, Weiman Gao, Chris Van den Haute, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3

Image-defined risk factors associated with MYCN oncogene amplification in neuroblastoma and their association with overall survival
Haoru Wang, Ting Li, Xiaoying Ni, et al.
Abdominal Radiology (2024) Vol. 49, Iss. 6, pp. 1949-1960
Closed Access | Times Cited: 3

CT-based morphologic and radiomics features for the classification of MYCN gene amplification status in pediatric neuroblastoma
Eelin Tan, Khurshid Merchant, Bhanu Prakash, et al.
Child s Nervous System (2022) Vol. 38, Iss. 8, pp. 1487-1495
Closed Access | Times Cited: 15

Reversing the HDAC-inhibitor mediated metabolic escape in MYCN-amplified neuroblastoma
Kausik Bishayee, Uddin Md. Nazim, Vijay Kumar, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 113032-113032
Open Access | Times Cited: 15

Roles of lncRNAs in childhood cancer: Current landscape and future perspectives
Fei Liu, Qian-Wen Xiong, Jinhu Wang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 8

Page 1 - Next Page

Scroll to top